Goodman Advisory Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.36M Buy
15,237
+14,808
+3,452% +$4.1M 0.77% 37
2026
Q1
$127K Buy
429
+273
+175% +$81.1K 0.03% 93
2025
Q4
$42.6K Buy
+156
New +$42.4K 0.01% 108
2023
Q3
Sell
-180
Closed -$35.8K 164
2023
Q2
$33.4K Hold
180
0.01% 93
2023
Q1
$34.5K Hold
180
0.02% 86
2022
Q4
$30K Hold
180
0.02% 87
2022
Q3
$32K Hold
180
0.02% 84
2022
Q2
$37K Buy
+180
New +$38.2K 0.02% 85

Other funds holding CME

Goodman Advisory Group's CME Position: Q2 2026 in Review

Goodman Advisory Group increased its CME Group (CME) stake by 3,452% in Q2 2026, buying an estimated $4.1M and bringing the position to 15,237 shares worth $3.36M. The position accounts for 0.77% of the portfolio, ranked #37.

Goodman Advisory Group first reported a position in CME in Q2 2022 and has held it in 8 quarters since. 1,702 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Goodman Advisory Group held 15,237 shares of CME Group worth $3.36M as of Q2 2026.
  • Goodman Advisory Group bought 14,808 CME Group shares in Q2 2026, an estimated $4.1M.
  • CME Group made up 0.77% of Goodman Advisory Group's portfolio in Q2 2026, its #37 holding.
  • Goodman Advisory Group first reported a position in CME Group in Q2 2022 and has held it in 8 quarters since.
  • 1,702 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.